Poster Session II - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.03 - HYPERACUTE MANAGEMENT P667 - ESOC25-2238 DIAGNOSTIC ACCURACY OF POINT-OF-CARE VISCOELASTIC ASSESSMENT OF DIRECT ORAL ANTICOAGULATION IN ACUTE ISCHEMIC STROKE: INTERIM RESULTS FROM A PROSPECTIVE VALIDATION STUDY Annahita Sedghi 1 , Eva Meyer-Bender 1 , Lars Heubner 2 , Joerg Pietsch 3 , Oliver Tiebel 4 , Kristian Barlinn 1 , Jan Beyer-Westendorf 5 , Volker Puetz 1 , Peter Spieth 2 , Timo Siepmann 1 1 Dresden Neurovascular Center, Department of Neurology, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany, 2 Department of Anesthesiology and Intensive Care Medicine, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany, 3 Institute of Legal Medicine, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany, 4 Institute of Clinical Chemistry, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany, 5 Thrombosis Research Unit, Department of Medicine I, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany Background and Aims: Intravenous thrombolysis in patients with acute ischemic stroke (AIS) is often delayed because of uncertainty about the presence of direct oral anticoagulants (DOACs)
Pathophysiology of MDS with isolated del(5q) MDS with isolated del(5q) is caused by the deletion of the DNA region in the long arm of chromosome 5
Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases
May Help Cardiovascular Health Some research showed sublingual glutathione to decrease vascular stiffness and reduce both total cholesterol and low-density lipoprotein (LDL) levels when used long-term
As these transport mechanisms take part in glutathione homeostasis we tested the susceptibility of different transporter mutants (Supplementary Table S1) to AITC
Signature: Myers MAX Our amazing Myers elevated for maximum benefit
